Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index; 7 of the 73 sources its claims cite were checked for support.
Abstract
BACKGROUND: Invasive candidiasis and candidemia are frequently encountered in the nosocomial setting, particularly in the intensive care unit (ICU). OBJECTIVES AND METHODS: To review the current management of invasive candidiasis and candidemia in non-neutropenic adult ICU patients based on a review of the literature and a European expert panel discussion. RESULTS AND CONCLUSIONS: Candida albicans remains the most frequently isolated fungal species followed by C. glabrata. The diagnosis of invasive candidiasis involves both clinical and laboratory parameters, but neither of these are specific. One of the main features in diagnosis is the evaluation of risk factor for infection which will identify patients in need of pre-emptive or empiric treatment. Clinical scores were built from those risk factors. Among laboratory diagnosis, a positive blood culture from a normally sterile site provides positive evidence. Surrogate markers have also been proposed like 1,3 beta-D: glucan level, mannans, or PCR testing. Invasive candidiasis and candidemia is a growing concern in the ICU, apart from cases with positive blood cultures or fluid/tissue biopsy, diagnosis is neither sensitive nor specific. The diagnosis remains difficult and is usually based on the evaluation of risk factors.
Overview
CoChat Summary
TL;DR
This narrative review summarizes the epidemiology and diagnosis of invasive candidiasis and candidemia in adult non-neutropenic ICU patients, emphasizing high attributable mortality and persistent diagnostic difficulty. It reports that Candida spp. are common ICU bloodstream pathogens, C. albicans remains predominant although non-albicans species are increasingly reported, and diagnosis relies on risk factors, colonization indices, cultures, and non-culture markers with imperfect accuracy.
Key findings
- Candida spp. account for 6–11% of positive nosocomial bloodstream infections; in a US surveillance study, 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections. ICU candidemia was 10.1% of bloodstream infections versus 7.9% on general wards, and one study reported 15.8/10,000 patient-days in ICUs versus 0.15/10,000 on medical wards and 0.69/10,000 on surgical wards.
- Attributable mortality of candidiasis was estimated at 49% in 108 matched pairs, with crude mortality 61% in case patients versus 12% in controls; a systematic review of seven matched cohort and case-control studies reported attributable mortality ranging from 5 to 71%. Invasive candidiasis and candidemia were associated with increased ICU and hospital stay of 12.7 and 15.5 days, respectively.
- C. albicans remained the main pathogen overall, but non-albicans species were increasingly reported. In an Italian ICU study of 182 candidemia episodes, 40% were C. albicans, 23% C. parapsilosis, 15% C. glabrata, 9% C. tropicalis, and 13% other species; in a Canadian 1-day point-prevalence study of 409 isolates, C. albicans accounted for 72% and C. glabrata 16%, with only 4% resistant to fluconazole and/or itraconazole.
- Diagnosis is challenging: clinical manifestations are non-specific, blood cultures are often positive late, and about 50% of blood culture samples may be inadequate (<20 mL). Reported test performance included beta-D-glucan sensitivity 69.9% and specificity 87.1%; combined mannan/antimannan sensitivity 80% and specificity 93%; and a PCR assay sensitivity 90.9% and specificity 100%. The Pittet colonization index threshold of 0.5 and a corrected index were associated with 100% sensitivity and specificity in a 29-patient study; the Leon Candida score cut-off of 2.5 had sensitivity 81% and specificity 74%.
Methods
- Narrative review of the international literature on management of invasive candidiasis and candidemia in adult non-neutropenic ICU patients, focused here on epidemiology and diagnosis.
- No primary patient cohort, systematic search strategy, or meta-analysis is described; the paper synthesizes findings from cited epidemiologic, risk-factor, prediction-rule, colonization-index, and laboratory-diagnostic studies.
- Main analysis is descriptive, covering incidence and mortality, Candida species distribution, risk factors, clinical prediction rules, colonization indices, and laboratory markers including beta-D-glucan, mannan/antimannan, germ tube antibody, and PCR.
Limitations
- The paper states that diagnosis is neither sensitive nor specific apart from positive blood cultures or fluid/tissue biopsy, and that there is a clear need for more specific diagnostic markers. It also states that uncertainty exists around the relative mortality of different Candida species, requiring well-controlled studies, and that the influence of azole prophylaxis on Candida epidemiology has not been clearly elucidated.
- The paper notes limitations of specific cited evidence, including that one prediction study involved only 19 patients with candidemia, that the Pittet colonization-index study evaluated 29 patients, that PCR results need further evaluation, and that beta-D-glucan requires validation in the appropriate ICU setting before routine use.
- Evident from the text: as a narrative review without a described systematic search or formal quality assessment, the reported incidence, species distribution, and mortality estimates vary widely across heterogeneous, often small, retrospective, or single-center studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 56 Not checked · 9 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“A larger study conducted over a 5-year period in Italy recorded 182 episodes of ICU candidemia, with an average incidence of 2.22 episodes/10,000 patient-days/ year [22].”
What the sources say
- Supportedcites [22] Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21 source
The Abstract Methods (p. 1) and Background/Methods sections establish a five-year (1999–2003) retrospective study in the ICU of San Martino University Hospital, Genoa, Italy. The Results (p. 1) and Table 2 state 182 episodes of candidaemia with an average incidence of 2.22 episodes/10 000 patient-days/year (range 1.25–3.06), matching every element of the claim. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The results of this study reflected a shift toward an increased rate of infection with non-albicans Candida species.”
What the sources say
- Supportedcites [22] Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21 source
The Background identifies the study as a retrospective analysis of bloodstream infections in an ICU in Genova, Italy. The Results report that the proportion of non-albicans isolates increased during 1999–2003, and the Discussion explicitly describes a shift toward non-albicans Candida species in the ICU population. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The authors developed a corrected index (product of the CI times the ratio of the number of dbs showing heavy growth to the total of dbs growing Candida spp.) which was associated with a 100% sensitivity and specificity.”
What the sources say
- Supportedcites [46] Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751-758 source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“and candidemia occurred more frequently in non-neutropenic patients than in patients with neutropenia [1,7].”
What the sources say
- Not checked yetcites [1] Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-317 source
- Not checked yetcites [7] Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY (2008) Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 34:292-299 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Comparing fluconazole-susceptible with resistant strains in 161 patients, Kovacicova et al. [19] found a significantly higher attributable mortality in patients infected with a fluconazole-resistant strain.”
What the sources say
- Not checked yetcites [19] Kovacicova G, Krupova Y, Lovaszova M, Roidova A, Trupl J, Liskova A, Hanzen J, Milosovic P, Lamosova M, Macekova L, Szovenyiova Z, Purgelova A, Obertik T, Bille J, Krcmery V (2000) Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia? J Infect Chemother 6:216- 221 source
plainstates an associationn = 161- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
15 more claims
Create a free account to see all 71 claims and to verify the 66 references still open.
- It may state two separate claims as one. 41
- Probably not a substantial claim. 18
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These possible treatment delays likely occurred because of the non-specific clinical presentation of candidemia, low sensitivity of blood cultures for candidemia detection, and the time needed to detect Candida in blood cultures [15, 27].”
From Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018. (2021) · cites this paper as [27]
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 4×
“varies depending on the population surveyed [1, 2].”
BackgroundInfluentialEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 4×
“varies depending on the population surveyed [1, 2].”
BackgroundInfluentialMorrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 1×
“specimens require invasive procedures [29, 30, 46].”
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · cited 1×
“Attributable mortality of candidiasis was evaluated retrospectively between 1997 and 2001 in 108 matched pairs [12], the crude mortality among case patients was 61% compared with 12% in”
ResultHospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798 · cited 2×
“specimens require invasive procedures [29, 30, 46].”
BackgroundOstrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669 · cited 1×
“1%, respectively [47], as there are a high number of false positive results.”
BackgroundBlumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661 · cited 3×
“Table 1 Commonly recognized risk factors for invasive Candida infection [2, 34, 35]”
BackgroundLeón, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Álvarez-Lerma, F., Garnacho-Montero, J., & León, M. Á. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202208.37364.7d · Cited by 659 · cited 3×
“[28] described a clinical score based on four parameters derived from a logit model: surgery, multifocal colonization, total parenteral nutrition, and severe sepsis.”
BackgroundMethodViscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 1×
“[18] also suggested that C.”
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509 · cited 1×
“[25] showed that Candida albicans was responsible for more than half of the cases in all patient populations.”
BackgroundEpidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478 · cited 1×
“Overall, ICU candidiasis represent one-third of all invasive candidiasis and is associated with a high mortality rate [11].”
BackgroundOstrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V., Kauffman, C. A., Kett, D., Larsen, R. A., Morrison, V., et al. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0270-z · Cited by 369 · cited 3×
“Several authors have used multivariate analyses in an attempt to assess independent risk factors associated with invasive candidiasis [28, 32, 33].”
BackgroundRisk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey, S. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100145030 · Cited by 369 · cited 1×
“[36] identified four factors associated with high risk of candidiasis: number of antibiotics received prior to infection (odds ratio (OR), 1.”
BackgroundTumbarello, M., Posteraro, B., Trecarichi, E. M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00131-07 · Cited by 343 · cited 1×
“[15] retrospectively studied the risk factors for mortality of patients with candidemia.”
BackgroundEpidemiological trends in nosocomial candidemia in intensive care
Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B., & Viscoli, C. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-21 · Cited by 332
The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
Rentz, A. M., Halpern, M. T., & Bowden, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514955 · Cited by 310 · cited 1×
“5 days, respectively, and increased total costs [8–10].”
BackgroundAttributable mortality of candidemia: a systematic review of matched cohort and case-control studies
Falagas, M. E., Apostolou, K. E., & Pappas, V. D. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0159-2 · Cited by 294 · cited 1×
“[14] also assessed the impact of candidemia on hospital mortality in a systematic review of seven matched cohort and case–control studies.”
BackgroundCurrent Treatment Strategies for Disseminated Candidiasis
Spellberg, B. J., Filler, S. G., & Edwards, J. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499057 · Cited by 256 · cited 1×
“diagnostic accuracy is still debated [29–31]; as a result, clinicians often disregard a potential diagnosis of candidiasis.”
BackgroundBougnoux, M.-E., Kac, G., Aegerter, P., d’Enfert, C., Fagon, J.-Y., & CandiRea Study Group (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0865-y · Cited by 224 · cited 2×
“[7] observed a mean incidence of candidemia of 6.”
BackgroundSendid, B., Tabouret, M., Poirot, J. L., Mathieu, D., Fruit, J., & Poulain, D. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.5.1510-1517.1999 · Cited by 202 · cited 1×
“This possibility was explored using 162 serum samples selected from 63 patients with clinically proven candidiasis, compared with 98 control samples [50].”
ResultDimopoulos, G., Ntziora, F., Rachiotis, G., Armaganidis, A., & Falagas, M. E. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181607262 · Cited by 189 · cited 1×
“The increasing incidence of non-albicans Candida species could be important, as a prospective study in a medical–surgical ICU suggested that candidemia due to non-albicans species was associated with higher mortality [16].”
BackgroundManagement and outcome of bloodstream infections due to Candida species in England and Wales
Kibbler, C. C., Seaton, S., Barnes, R. A., Gransden, W. R., Holliman, R. E., Johnson, E. M., Perry, J. D., Sullivan, D. J., & Wilson, J. A. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00085-9 · Cited by 187 · cited 1×
“7% of confirmed cases [24].”
Self-citationPetri, M. G., König, J., Moecke, H. P., Gramm, H. J., Barkow, H., Kujath, P., Dennhart, R., Schäfer, H., Meyer, N., Kalmar, P., et al. (1997) · Intensive Care Medicine · doi:10.1007/s001340050334 · Cited by 185 · cited 1×
“[43] showed that 64% of ICU patients were colonized, and that all infected patients had been previously colonized.”
BackgroundPaphitou, N. I., Ostrosky-Zeichner, L., & Rex, J. H. (2005) · Medical Mycology · doi:10.1080/13693780410001731619 · Cited by 179 · cited 2×
“Several authors have used multivariate analyses in an attempt to assess independent risk factors associated with invasive candidiasis [28, 32, 33].”
BackgroundArendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Jensen, I. M., Knudsen, J. D., Lundgren, B., Schønheyder, H. C., & Tvede, M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4434-4440.2005 · Cited by 178 · cited 1×
“9 cases/100,000/year in the hospital population [3–5].”
Self-citationDupont, H. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.12.1341 · Cited by 163 · cited 1×
“identified: the Apache II score, respiratory failure on admission, upper gastrointestinal tract site peritonitis, and positive results for Candida following direct testing of peritoneal fluid [38].”
BackgroundFungal Infections in Patients with Severe Acute Pancreatitis and the Use of Prophylactic Therapy
De Waele, J. J., Vogelaers, D., Blot, S., & Colardyn, F. (2003) · Clinical Infectious Diseases · doi:10.1086/375603 · Cited by 156
SENDID, B., POIROT, J. L., TABOURET, M., BONNIN, A., CAILLOT, D., CAMUS, D., & POULAIN, D. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-5-433 · Cited by 156 · cited 1×
“This test was also effective with non-albicans Candida species [51].”
MethodEconomic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient
Jord�, R., Nolla‐Salas, J., Le�n-Regidor, M. A., lvarez-Lerma, F., Olaechea, P., Palomar, M., & Le�n-Gil, C. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1104-x · Cited by 145 · cited 1×
“5 days, respectively, and increased total costs [8–10].”
BackgroundMcMullan, R., Metwally, L., Coyle, P. V., Hedderwick, S., McCloskey, B., O'Neill, H. J., Patterson, C. C., Thompson, G., Webb, C. H., & Hay, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/528690 · Cited by 145 · cited 1×
“9% sensitivity, and 100% specificity suggesting a potential usefulness of this method [56].”
MethodArendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Schønheyder, H. C., Knudsen, J. D., Jensen, I., Bruun, B., Christensen, J. J., & Johansen, H. K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01954.x · Cited by 134 · cited 1×
“9 cases/100,000/year in the hospital population [3–5].”
Self-citationCandidemia in Finland, 1995–1999
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., & Ruutu, P. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030069 · Cited by 121 · cited 1×
“9 cases/100,000/year in the hospital population [3–5].”
Determinants of Candidemia and Candidemia-Related Death in Cardiothoracic ICU Patients
Michalopoulos, A. S., Geroulanos, S., & Mentzelopoulos, S. D. (2003) · Chest · doi:10.1378/chest.124.6.2244 · Cited by 121 · cited 1×
“[42] identified independent predictive factors and prospectively validated them in two centers.”
BackgroundShorr, A. F., Lazarus, D. R., Sherner, J. H., Jackson, W. L., Morrel, M., Fraser, V. J., & Kollef, M. H. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000259379.97694.00 · Cited by 101 · cited 1×
“in a recently published study [23].”
Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit
Muñoz, P., Burillo, A., & Bouza, E. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00147-3 · Cited by 95 · cited 1×
“Other risk factors have also been identified, such as the presence of a central venous catheter [21] or hemodialysis [40].”
BackgroundTreatment options of invasive fungal infections in adults
Marchetti, O., Eggimann, P., Pittet, D., Glauser, M., & Calandra, T. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11392 · Cited by 90 · cited 2×
“specimens require invasive procedures [29, 30, 46].”
MethodAgvald-Öhman, C., Klingspor, L., Hjelmqvist, H., & Edlund, C. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701534509 · Cited by 87 · cited 1×
“These observations were confirmed in a recent study in 59 consecutive multidisciplinary ICU patients where both high colonization index and recent extensive gastro-abdominal surgery were correlated with invasive candidiasis and candidemia [39].”
ResultOutcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata
Blot, S., Vandewoude, K., Hoste, E., Poelaert, J., & Colardyn, F. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0918 · Cited by 73 · cited 1×
“[17] compared critically ill patients with fungemia due to C.”
BackgroundTherapy and outcome of Candida glabrata versus Candida albicans bloodstream infection
Klevay, M. J., Ernst, E. J., Hollanbaugh, J. L., Miller, J. G., Pfaller, M. A., & Diekema, D. J. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.10.001 · Cited by 73 · cited 1×
“7) in a recent case control study [20], suggesting that uncertainty exists around the relative mortality of different Candida species, requiring well-controlled studies.”
BackgroundInvasive Candidiasis: Turning Risk into a Practical Prevention Policy?
Sobel, J. D., & Rex, J. H. (2001) · Clinical Infectious Diseases · doi:10.1086/321812 · Cited by 73 · cited 2×
“Table 1 Commonly recognized risk factors for invasive Candida infection [2, 34, 35]”
BackgroundSendid, B., Jouault, T., Coudriau, R., Camus, D., Odds, F., Tabouret, M., & Poulain, D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.164-171.2004 · Cited by 69 · cited 1×
“The results showed a slight improvement in specificity to 95%, with a sensitivity of 90% [52].”
BackgroundDolores Moragues, M., Ortiz, N., Ramón Iruretagoyena, J., García-Ruiz, J. C., Amutio, E., Rojas, A., Mendoza, J., Quindós, G., & Pontón-San Emeterio, J. (2004) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(04)73039-6 · Cited by 56
Stéphan, F., Sialou Bah, M., Desterke, C., Rézaiguia‐Delclaux, S., Foulet, F., Duvaldestin, P., & Bretagne, S. (2002) · Clinical Infectious Diseases · doi:10.1086/344648 · Cited by 56 · cited 1×
“More recent studies using microsatellite markers have confirmed that, in most cases, the fungal acquisition was mainly endogenous [44, 45].”
BackgroundCandidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients
Hadley, S., Lee, W. W., Ruthazer, R., & Nasraway, S. A. (2002) · Critical Care Medicine · doi:10.1097/00003246-200208000-00023 · Cited by 46 · cited 1×
“it was associated with a very high mortality rate [13].”
BackgroundSusceptibility patterns of Candida species recovered from Canadian intensive care units
Laverdiere, M., Labbé, A.-C., Restieri, C., Rotstein, C., Heyland, D., Madger, S., & Stewart, T. (2007) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.10.038 · Cited by 42 · cited 4×
“In Canada, 409 Candida isolates were recovered during a 1-day point-prevalence study in 35 ICUs [27].”
BackgroundInfluentialSelf-citationLaín, A., Elguezabal, N., Brena, S., García-Ruiz, J. C., del Palacio, A., Moragues, M. D., & Pontón, J. (2007) · BMC Microbiology · doi:10.1186/1471-2180-7-35 · Cited by 40
Kovacicova, G., Krupova, Y., Lovaszova, M., Obertik, T., Krcmery, V., Roidova, A., Trupl, J., Liskova, A., Hanzen, J., Milosovic, P., et al. (2000) · Journal of Infection and Chemotherapy · doi:10.1007/s101560070006 · Cited by 39 · cited 1×
“[19] found a significantly higher attributable mortality in patients infected with a fluconazole-resistant strain.”
BackgroundThe Diagnostic Value of Fungal Surveillance Cultures in Critically Ill Patients
Pelz, R. K., Lipsett, P. A., Swoboda, S. M., Diener-West, M., Hammond, J. M., & Hendrix, C. W. (2000) · Surgical Infections · doi:10.1089/109629600750067200 · Cited by 36 · cited 2×
“[41] showed a clear increase in risk beyond the seventh day of stay.”
BackgroundEloy, O., Marque, S., Botterel, F., Stephan, F., Costa, J.-M., Lasserre, V., & Bretagne, S. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-162 · Cited by 35 · cited 1×
“More recent studies using microsatellite markers have confirmed that, in most cases, the fungal acquisition was mainly endogenous [44, 45].”
BackgroundSecular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital
Luzzati, R., Allegranzi, B., Antozzi, L., Masala, L., Pegoraro, E., Azzini, A., & Concia, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01268.x · Cited by 33 · cited 1×
“[6] reported a study showing that candidemia occurred more frequently in ICUs than on either surgical or general medical wards.”
Ashworth, P. M. (1978) · PubMed · Cited by 33
Candidaemia in a large teaching hospital: a clinical audit
Aliyu, S. H. (2006) · QJM · doi:10.1093/qjmed/hcl087 · Cited by 31 · cited 2×
“Other risk factors have also been identified, such as the presence of a central venous catheter [21] or hemodialysis [40].”
BackgroundFukazawa, Y. (1989) · PubMed · Cited by 29
Comert, F., Kulah, C., Aktas, E., Eroglu, O., & Ozlu, N. (2007) · Mycoses · doi:10.1111/j.1439-0507.2006.01309.x · Cited by 28 · cited 1×
“8%) [26].”
Poulain, D., Robert, R., Mesnard, F., Sendid, B., Lepage, G., & Camus, D. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01575114 · Cited by 18
Use of PCR Based Diagnosis for Common Invasive Fungal Infections in the Intensive Care Unit
Arishima, T., & Takezawa, J. (2006) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.47.283 · Cited by 6 · cited 1×
“[55].”
Cited by
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454
“ICU-acquired candidemia patients characteristically have several underlying medical and surgical risk factors, and are frequently exposed to high-risk medications [5].”
BackgroundInvasive candidiasis as a cause of sepsis in the critically ill patient
Delaloye, J., & Calandra, T. (2014) · Virulence · doi:10.4161/viru.26187 · Cited by 372
The Changing Epidemiology of Invasive Fungal Infections
Enoch, D. A., Yang, H., Aliyu, S. H., & Micallef, C. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6515-1_2 · Cited by 370
Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366
“Candida species are among the most common causes of BSIs and are associated with high morbidity and mortality, as well as increases in hospital cost and length of stay [1–5].”
Influentialde Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 350
“Candidemia is such an important infection that in 10–40% of cases it is associated with sepsis or septic shock while Candida species as main agent of sepsis or septic shock are responsible for no more than 5% of the total number of cases (Guery et al., 2009).”
Background
Metadata
- Authors
- Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., Venditti, M., Zaragoza Crespo, R., & Kullberg, B. J.
- Affiliations
- Statens Serum Institut (DK)
- King's College Hospital (GB)
- Hôpital Saint-Louis (FR)
- University Hospitals of the Ruhr-University of Bochum (DE)
- University of Bonn (DE)
- University Health Network (CA)
- Università Cattolica del Sacro Cuore (IT)
- Sapienza University of Rome (IT)
- Radboud University Nijmegen (NL)
- Corresponding author
- Kullberg, Bart Jan
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2008-10-30
- Volume
- 35
- Issue
- 1
- Pages
- 55-62
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2012383276
- Semantic Scholar
- cd5e9d6d2f04b85eba8f5f641d0d646b8f63bdb4
- Cited by
- 173
- References
- 58
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 4 · 2017: 11 · 2016: 15 · 2015: 17 · 2014: 18 · 2013: 14 · 2012: 11
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Intensive Care Medicine (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by-nc)
- Hispana (submittedVersion, cc-by-nc)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Pfizer
- Sanofi
- Gilead Sciences
- Fresenius Medical Care North America
- Astellas Pharma
- Novartis Pharma
- Bayer Vital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- invasive candidiasis, candidemia, non-neutropenic patients, intensive care unit, Candida albicans, Candida glabrata, nosocomial fungal infections, risk factors, clinical scoring systems, blood culture, β-1,3-glucan, mannan, PCR detection, antifungal therapy, epidemiology
- MeSH terms
- Candidiasis, Cross Infection, Europe, Humans, Intensive Care Units, Turkey, Biomarkers, Prevalence, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.